Small intestinal bacterial overgrowth (SIBO) has been linked to common gastrointestinal symptoms; yet its precise definition remains elusive. A new study shows that, when it comes to symptom prediction in functional gastrointestinal disorders, high-throughput sequencing analysis of the microbiome and not jejunal aspiration and culture is the clear winner.

Original languageEnglish (US)
Pages (from-to)457-458
Number of pages2
JournalNature Reviews Gastroenterology and Hepatology
Issue number8
StatePublished - Aug 1 2019

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology


Dive into the research topics of 'Symptoms and the small intestinal microbiome — the unknown explored'. Together they form a unique fingerprint.

Cite this